ZIOPHARM Announces Oral Presentation Highlighting Ad-RTS-IL-12...

Ad-RTS-IL-12 is a novel DNA-based therapeutic candidate for the controlled expression of IL-12, an important protein for stimulating an anti-cancer T cell immune response.

http://ift.tt/1lYHPDX